Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/69491
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Barbosa, Guilherme Correa | - |
dc.contributor.author | Moreno, Vânia | - |
dc.contributor.author | Juliani, Carmen Maria Casquel Monti | - |
dc.contributor.author | Spiri, Wilza Carla | - |
dc.contributor.author | Molina Lima, Silvana Andrea | - |
dc.date.accessioned | 2014-05-27T11:22:23Z | - |
dc.date.accessioned | 2016-10-25T18:23:30Z | - |
dc.date.available | 2014-05-27T11:22:23Z | - |
dc.date.available | 2016-10-25T18:23:30Z | - |
dc.date.issued | 2007-01-01 | - |
dc.identifier | http://dx.doi.org/10.4025/actascihealthsci.v29i1.118 | - |
dc.identifier.citation | Acta Scientiarum - Health Sciences, v. 29, n. 1, p. 19-23, 2007. | - |
dc.identifier.issn | 1679-9291 | - |
dc.identifier.uri | http://hdl.handle.net/11449/69491 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/69491 | - |
dc.description.abstract | The present work aims to raise the costs of high-cost drugs used to treat patients of Refractory Schizophrenia in ambulatory unit. The study was carried out in the Psychosocial Support Center, which treated 33 patients with these medications, during the period of June, 2005 to May, 2006. Data analysis disclosed that the mostly used drugs to treat the carriers of Refractory Schizophrenia were: clozapina and risperidona. It was observed that the treatment with olanzapina is more expensive than that with risperidona. The study concluded that the analysis of the consumption and costs of drugs of high cost is necessary to subside better management of the expenses and new investments in the service. Moreover, the necessity of more studies in the area was also identified to contribute with the control of costs. | en |
dc.format.extent | 19-23 | - |
dc.language.iso | por | - |
dc.source | Scopus | - |
dc.subject | Atypical antipsychotics | - |
dc.subject | Costs | - |
dc.subject | Schizophrenia | - |
dc.subject | clozapine | - |
dc.subject | neuroleptic agent | - |
dc.subject | olanzapine | - |
dc.subject | quetiapine | - |
dc.subject | risperidone | - |
dc.subject | ziprasidone | - |
dc.subject | ambulatory care | - |
dc.subject | clinical article | - |
dc.subject | controlled study | - |
dc.subject | cost control | - |
dc.subject | cost effectiveness analysis | - |
dc.subject | drug cost | - |
dc.subject | drug use | - |
dc.subject | human | - |
dc.subject | mental health service | - |
dc.subject | schizophrenia | - |
dc.title | Medicação de alto custo para portador de sofrimento psíquico: Um estudo preliminar dos custos | pt |
dc.title.alternative | High cost drugs for carrier of psychic suffering: A preliminary study of costs | en |
dc.type | outro | - |
dc.contributor.institution | Faculdade de Medicina de Marília (FAMEMA) | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.description.affiliation | Área de Enfermagem Psiquiátrica Faculdade de Medicina de Marilia, Marilia, São Paulo | - |
dc.description.affiliation | Departamento de Enfermagem Faculdade de Medicina de Botucatu Universidade Estadual Paulista, Rubião Junior, s/n, 18618-970 Botucatu, São Paulo | - |
dc.description.affiliationUnesp | Departamento de Enfermagem Faculdade de Medicina de Botucatu Universidade Estadual Paulista, Rubião Junior, s/n, 18618-970 Botucatu, São Paulo | - |
dc.identifier.doi | 10.4025/actascihealthsci.v29i1.118 | - |
dc.rights.accessRights | Acesso aberto | - |
dc.identifier.file | 2-s2.0-55049109893.pdf | - |
dc.relation.ispartof | Acta Scientiarum: Health Sciences | - |
dc.identifier.scopus | 2-s2.0-55049109893 | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.